- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$21.31 BnMarket Estimate, 2026
$21.80 BnMarket Forecast, 2034
$26.19 BnCAGR, 2026–2034
2.32%Executive Summary: North America Blood Testing Market
- Market Scope: Comprehensive North American blood testing market analysis covering test types, disease indications, testing methods, regional leadership frameworks, and adoption metrics.
- Market Valuation: Valued at USD 21.31 billion (2025), reaching USD 21.80 billion (2026), and projected to grow to USD 26.19 billion by 2034, registering a stable CAGR of 2.32% (2026–2034).
- Primary Growth Drivers: Driven by the rising prevalence of chronic diseases (diabetes, cardiovascular disorders, cancer, and infectious diseases), increased routine diagnostic testing, blood donation campaigns, technological advancements, and growing preventive healthcare awareness. Key challenges include shortages of testing materials, skilled professional deficits, procedural discomfort, and testing infrastructure limitations.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Type | Complete Blood Count (CBC) and Blood Chemistry Tests (led market demand for routine evaluations) | Specialized Enzyme and Clotting Tests (driven by advanced cardiovascular and metabolic monitoring) |
| By Disease | Infections and Anemia (accounted for major routine screening volumes) | Kidney Disorders and Heart-related conditions (projected to witness high demand due to rising chronic burdens) |
| By Method | Automated Blood Culture Testing (dominated laboratory workflows for efficiency) | Automated Testing Solutions (expanding rapidly via high-throughput diagnostic systems) |
| By Region | United States (largest market, supported by high testing volumes and strong healthcare spending) | Canada (growing steadily via advanced blood testing technologies and public health initiatives) |
Major Market Players & Market Structure
Market Structure: Highly competitive North American diagnostic landscape characterized by continuous investments in diagnostic innovation, automated blood culture systems, advanced molecular diagnostics, strategic collaborations, product launches, and expanding laboratory testing capabilities. Companies compete through technological advancements, accuracy, turnaround time, regulatory compliance, and broad diagnostic portfolios.
Key Companies: Bio-Rad Laboratories Inc., Siemens Healthcare, Grifols, Nanosphere Inc., bioMérieux, Becton, Dickinson and Company (BD), Ortho Clinical Diagnostics Inc., Roche Diagnostics, Alere Inc., Bruker Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., and Beckman Coulter.
North America Blood Testing Market Size
The North America blood testing market is growing steadily and was valued at USD 21.31 billion in 2025. The market in North America is anticipated to register a CAGR of 2.32% from 2026 to 2034 and be worth from USD 21.80 billion in 2026 to USD 26.19 billion by 2034.
MARKET DRIVERS
YOY growth in the number of people suffering from chronic diseases in North American countries is one of the primary factors driving the blood testing market in the North American region. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six in ten adults in the United States suffer from at least one chronic disease, such as cancer, heart disease, or diabetes. Chronic diseases are the primary reason for the death of many people in the United States. A blood test can help predict future risks in a person. Nearly half of the older people in the U.S. are prone to chronic diseases such as diabetes and heart disease. One in 3 people above 60 years of age suffers from type 1 and type 2 diabetes. These people need to regularly check glucose levels in their blood, which is done through blood tests that drive the market forward in this region.
YOY rise in the number of blood donations and blood donation campaigns are further boosting the blood testing market in the North American region. Nearly 5 percent of people in the U.S. have donated blood every year. Blood donation is a process that starts with a blood test. Most of the people who want to donate blood should know about the blood group that they are having. For this reason, blood tests play an important role. The people who need to donate blood must undergo many tests to ensure they are not suffering from chronic diseases.
A growing number of people suffering from infectious and seasonal diseases is also propelling the North American blood testing market. Due to the COVID-19 pandemic, most people are undergoing this blood test to detect the virus in their blood. This is the most preferred test during the pandemic, which drives the blood testing market in this region. During this pandemic, most people need platelets to cure diseases. These people also undergo a blood test to check their platelet levels. Other diseases, such as hemoglobin levels in women, also require this blood test. Most women suffer from deficient hemoglobin due to various issues. These people require frequent blood testing, which drives the market forward. In addition, the market participants are manufacturing a disposable blood testing device that helps prevent diseases from spreading from patients to healthcare providers, which drives the market forward.
MARKET RESTRAINTS
However, the shortage of blood test material is anticipated to hamper this region's blood testing market growth. Blood tests need trained professionals, which otherwise leads to a severe blood infection, another primary factor restraining the market growth. Additionally, blood testing is a painful process that may hamper market growth. The lack of correct instruments for the blood test also restrained the market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Analyzed | By Type, Disease, Method & Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | The U.S., Canada, Mexico, Rest of North America. |
| Key Market Players | Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.). |
REGIONAL ANALYSIS
The North American region had the most significant share of the global market in 2025. More than 7 billion blood tests are performed in the U.S. each year. This is increased due to increasing awareness among people about keeping their bodies healthy. This blood test will help to track the overall body condition. In addition, the increased blood and platelets needed for patients every 60 seconds in the U.S. boost the market. Due to the increasing number of Alzheimer's cases in the United States, the researcher found an advance in technologies that early signs of Alzheimer's disease can be detected by using a simple blood test.
Different types of technology are used on the blood, which is taken for blood tests by scientists at the Public Health Agency of Canada's National Microbiology Laboratory (NML), for finding various blood-borne and sexually transmitted infections in the body. Considering all these factors, the market has a large share in this region.
KEY MARKET PLAYERS
A few of the companies that are playing a notable role in the North American blood testing market profiled in the report are
- Bio-Rad Laboratories Inc. (U.S.)
- Siemens Healthcare (Germany)
- Grifols (Spain)
- Nanosphere Inc. (U.S.)
- bioMérieux (France)
- Becton, Dickinson and Company (U.S.)
- Ortho Clinical Diagnostics Inc. (U.S.)
- Roche Diagnostics (Switzerland)
- Alere Inc. (U.S.)
- Bruker Corporation (U.S.)
- Abbott Laboratories (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Beckman Coulter (U.S.)
MARKET SEGMENTATION
This research report on the North American blood testing market is segmented and sub-segmented into the following categories.
By Type
- Complete Blood Count
- Blood Chemistry Tests
- Blood Enzymes Tests
- Blood Clotting Tests
By Disease
- Anemia
- Infection
- Leukemia
- Hypokalemia
- Kidney Disorders
- Heart Attack
- Coronary Heart Disease
By Method
- Manual Blood Culture Testing
- Automated Blood Culture Testing
By Region
- The United States
- Canada
- Rest of North America